Isocitrate dehydrogenase (IDH) enzymes IDH1 and IDH2 are frequently mutated in several cancers and a gain-of-function activity promotes conversion of α-ketoglutarate (α-KG) to the oncometabolite 2-Hydroxyglutarate (2-HG) [34, 35]. The gene discussed is IDH2; the disease is cancer.